News Focus
News Focus
icon url

Threes

08/12/18 12:40 PM

#327989 RE: biopharm #327987

So we found a subgroup from Sunrise trials that appear to respond well how do we quantify and monetize that. Well they probably would give us a Phase 3. Great $40 MM we do not have to chase a success that is FAR FAR from guaranteed. 5 years from inception to NDA application. So let's spend money we do not have for results we cannot guarantee. Looks like a recipe for the next RS.

Or partner get $95 MM in milestones, Royalties in the teens and sell Bavi for what should be multiple trials and testing for years to come. If you bought in in your twenties you'll be 70 hoping this time the trial does not have the standard PPHM whammy. Another kick in the gut.

Personally since the takeover looking at my portfolio has been much more pleasant. lot's of green lately.



You do realize the sub group was evident while ES, CJ, PL, SK were at the helm.
Even with that info. they could not partner, license, or sell the IP to save their asses.